Mike Bromley

Mike Bromley has over 15 years of experience in medical mycology research. He works on the mechanistic basis of fungal pathogenicity with the translational emphasis of developing novel antifungal agents. Whilst working for F2G Ltd, a University of Manchester spin-out company, Mike made a major contribution to the identification of potential drug targets in A. fumigatusand to advancing these discoveries through target validation to drug development.

His